{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:06:03Z","timestamp":1790809563781,"version":"4.1.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,3,23]]},"DOI":"10.18632\/oncotarget.24598","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T19:13:13Z","timestamp":1519845193000},"page":"16149-16162","source":"Crossref","is-referenced-by-count":15,"title":["Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression <i>in vivo<\/i>"],"prefix":"10.18632","volume":"9","author":[{"given":"Emilie","family":"Indersie","sequence":"first","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna B.","family":"Hooks","sequence":"additional","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Capdevielle","sequence":"additional","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Fabre","sequence":"additional","affiliation":[{"name":"Necker Hospital, Paris 75015, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dugot-Senant","sequence":"additional","affiliation":[{"name":"Plateforme d\u2019histologie UMS 005, Bordeaux 33000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Desplat","sequence":"additional","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lepreux","sequence":"additional","affiliation":[{"name":"Service de Pathologie, CHU de Bordeaux, Bordeaux 33000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksam","family":"Merched","sequence":"additional","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe F.","family":"Grosset","sequence":"additional","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"University Bordeaux, INSERM U1035, miRCaDe team, Bioth\u00e9rapie des Maladies G\u00e9n\u00e9tiques, Inflammatoires et du Cancer, Bordeaux 33076, France"},{"name":"University Bordeaux, INSERM U1035, Bordeaux Research in Translational Oncology (Bariton), Bordeaux 33076, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"e23419","DOI":"10.1371\/journal.pone.0023419","article-title":"Successful establishment of an orthotopic hepatoblastomamodel in NOD\/LtSz-scid IL2Rgammanull mice","volume":"6","author":"Fuchs","year":"2011","journal-title":"PLoS One"},{"key":"2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jhep.2006.03.018","article-title":"Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice","volume":"45","author":"Kohler","year":"2006","journal-title":"J Hepatol"},{"key":"3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fped.2016.00022","article-title":"Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies","volume":"4","author":"Howard","year":"2016","journal-title":"Front Pediatr"},{"key":"4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"Fabr\u00e8","year":"2014","journal-title":"Mod Pathol"},{"key":"5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Birch","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"6","first-page":"493","article-title":"Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies","volume":"4","author":"Schweinitz","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3978\/j.issn.2224-4336.2014.09.01","article-title":"Pediatric hepatoblastoma: diagnosis and treatment","volume":"3","author":"Hiyama","year":"2014","journal-title":"Transl Pediatr"},{"key":"8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Rangaswami","year":"2013","journal-title":"Lancet Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2741\/e393","article-title":"Activation of Wnt and Myc signaling in hepatoblastoma","volume":"4","author":"Buendia","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/hep.22649","article-title":"Blocking the hedgehog pathway inhibits hepatoblastoma growth","volume":"49","author":"Kappler","year":"2009","journal-title":"Hepatology"},{"key":"11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<399::AID-GCC14>3.0.CO;2-X","article-title":"Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma","volume":"25","author":"Otto","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/hep.27243","article-title":"Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex","volume":"60","author":"Xia","year":"2014","journal-title":"Hepatology"},{"key":"13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hep4.1029","article-title":"MicroRNA therapy inhibits hepatoblastoma growthby targeting \u03b2-catenin and Wnt signaling","volume":"1","author":"Guettier","year":"2017","journal-title":"Hepatol Commun"},{"key":"14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Levillayer","year":"2008","journal-title":"Cancer Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/dvdy.20020","article-title":"VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis","volume":"230","author":"Bikfalvi","year":"2004","journal-title":"Dev Dyn"},{"key":"16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1073\/pnas.0408622102","article-title":"Accessing key steps of human tumor progressionby using an avian embryo model","volume":"102","author":"Bikfalvi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"17","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.18632\/oncotarget.1490","article-title":"Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5","volume":"4","author":"Bicknell","year":"2013","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1158\/0008-5472.CAN-04-1014","article-title":"Hepatocyte growth factor\/c-Met signaling promotes the progression of experimental human neuroblastomas","volume":"64","author":"Schweigerer","year":"2004","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"1606 e1","DOI":"10.1053\/j.gastro.2009.12.061","article-title":"Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells","volume":"138","author":"Hagedorn","year":"2010","journal-title":"Gastroenterology"},{"key":"20","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1158\/0008-5472.CAN-15-2864","article-title":"Dual roles for CXCL4 chemokines and CXCR3 in angiogenesis and invasion of pancreatic cancer","volume":"76","author":"Wodrich","year":"2016","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Salzberg","year":"2015","journal-title":"Nat Methods"},{"key":"22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Shi","year":"2014","journal-title":"Bioinformatics"},{"key":"23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Anders","year":"2014","journal-title":"Genome Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1073\/pnas.0914072107","article-title":"Inositol-requiring enzyme 1alpha is a key regulator of angiogene sis and invasion in malignant glioma","volume":"107","author":"Vajkoczy","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"25","doi-asserted-by":"publisher","first-page":"e22620","DOI":"10.4161\/onci.22620","article-title":"Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma","volume":"2","author":"Fuchs","year":"2013","journal-title":"OncoImmunology"},{"key":"26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1756-0500-3-58","article-title":"Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane","volume":"3","author":"Hagedorn","year":"2010","journal-title":"BMC Res Notes"},{"key":"27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1471-2407-11-241","article-title":"A short-termmodel for giant cell tumor of bone","volume":"11","author":"Hagedorn","year":"2011","journal-title":"BMC Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1038\/sj.onc.1207782","article-title":"Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas","volume":"23","author":"Ando","year":"2004","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng.3224","article-title":"Stromal contribution to the colorectal cancer transcriptome","volume":"47","author":"Fekete","year":"2015","journal-title":"Nat Genet"},{"key":"30","doi-asserted-by":"publisher","first-page":"17456","DOI":"10.1073\/pnas.1114210108","article-title":"Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis","volume":"108","author":"Lee","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"31","doi-asserted-by":"publisher","first-page":"e66003","DOI":"10.1371\/journal.pone.0066003","article-title":"RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib","volume":"8","author":"Barry","year":"2013","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2043-9113-3-8","article-title":"Characteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarrays","volume":"3","author":"Clarke","year":"2013","journal-title":"J Clin Bioinforma"},{"key":"33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-3468(96)90242-0","article-title":"Successful transplantation of human hepatoblastoma into immunodeficient mice","volume":"31","author":"von Schweinitz","year":"1996","journal-title":"J Pediatr Surg"},{"key":"34","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.14800\/ccm.439","article-title":"Role of caveolin-2 in subcutaneous tumor growth and angiogenesis associated with syngeneic mouse Lewis lung carcinoma and B16 melanoma models","volume":"1","author":"Sowa","year":"2014","journal-title":"Cancer Cell Microenviron"},{"key":"35","doi-asserted-by":"publisher","first-page":"e7856","DOI":"10.1371\/journal.pone.0007856","article-title":"Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system","volume":"4","author":"Hagedorn","year":"2009","journal-title":"PLoS One"},{"key":"36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1158\/1535-7163.MCT-15-0583","article-title":"Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growthby Affecting Stroma","volume":"15","author":"Opitz","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/jmcb\/mjv014","article-title":"Ribosomal proteins: functions beyond the ribosome","volume":"7","author":"Lu","year":"2015","journal-title":"J Mol Cell Biol"},{"key":"38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/dvdy.21815","article-title":"Many ribosomal protein mutations are associated with growth impairment and tumor predisposition in zebrafish","volume":"238","author":"Lees","year":"2009","journal-title":"Dev Dyn"},{"key":"39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00432-008-0538-4","article-title":"Down-regulation of ribosomal protein L7A in human osteosarcoma","volume":"135","author":"Tang","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"e79117","DOI":"10.1371\/journal.pone.0079117","article-title":"Small ribosomal protein subunit S7 suppresses ovarian tumorigenesis through regulation of the PI3K\/AKT and MAPK pathways","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1593\/neo.91610","article-title":"RPL41, a small ribosomal peptide deregulated in tumors, is essen tial for mitosis and centrosome integrity","volume":"12","author":"Xiao","year":"2010","journal-title":"Neoplasia"},{"key":"42","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nature01627","article-title":"Humanin peptide suppresses apoptosis by interfering with Bax activation","volume":"423","author":"Reed","year":"2003","journal-title":"Nature"},{"key":"43","doi-asserted-by":"publisher","first-page":"15825","DOI":"10.1074\/jbc.M413062200","article-title":"Cytoprotective peptide humanin binds and inhibits proapoptotic Bcl-2\/Bax family protein BimEL","volume":"280","author":"Reed","year":"2005","journal-title":"J Biol Chem"},{"key":"44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2826","article-title":"The Hox genes and their roles in oncogenesis","volume":"10","author":"Sukumar","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"45","doi-asserted-by":"publisher","first-page":"e112024","DOI":"10.1371\/journal.pone.0112024","article-title":"FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast","volume":"9","author":"Gromova","year":"2014","journal-title":"PLoS One"},{"key":"46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/1541-7786.MCR-05-0267","article-title":"Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer","volume":"4","author":"Marrero","year":"2006","journal-title":"Mol Cancer Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.4161\/cc.22137","article-title":"Ketone body utilization drives tumor growth and metastasis","volume":"11","author":"Lisanti","year":"2012","journal-title":"Cell Cycle"},{"key":"48","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.28397","article-title":"MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma","volume":"63","author":"Shi","year":"2016","journal-title":"Hepatology"},{"key":"49","doi-asserted-by":"publisher","first-page":"e26450","DOI":"10.1371\/journal.pone.0026450","article-title":"Enhanced activity of meprin-alpha, a pro-migratory and pro-angiogenic protease, in colorectal cancer","volume":"6","author":"Stocker","year":"2011","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2012.07.023","article-title":"Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model","volume":"326","author":"De Wever","year":"2012","journal-title":"Cancer Lett"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:18:55Z","timestamp":1589037535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,3,23]]}},"alternative-id":["24598","29662633"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24598","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]}}}